Target engagement biomarker quantitates pharmaceutical binding to intended molecular target validating mechanism engagement. Receptor occupancy measurement confirms target binding. Pathway activation indicates downstream effect. Dose-dependent engagement characterises saturation kinetics. Target selectivity assessment confirms specificity.
Regulatory submissions employ engagement evidence. Clinical outcomes correlate with engagement levels. Biomarker-driven dosing optimises engagement. Post-approval monitoring confirms engagement maintenance. Emerging imaging enables visualised engagement.
General Biopharmaceutical Concepts
Target Engagement Biomarker
A target engagement biomarker demonstrates that a therapeutic product has successfully interacted with its intended biological target in vivo.
Continue Exploring
Browse over 900 biopharmaceutical terms across biologics, ADCs, cell & gene therapy, CMC, clinical development and manufacturing.
Browse Glossary →